Delivery Order SPE2DB20D1100-SPE2DB25FE6V9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation has an ultimate completion date of September 16, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a $22,375.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with performance to be completed by September 9, 2025. This contract award employs firm fixed price terms and carries no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a $11,187.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitive, non-set-aside contract award is classified as a firm fixed price delivery order with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) with an ultimate completion date of August 8, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77, with completion expected by April 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $11,187.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6V9Delivery Order
The Defense Logistics Agency awarded a $5,593.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with an ultimate completion date of October 6, 2025. This is a competitive, non-set-aside award issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to the Defense Health Agency and military healthcare systems, providing a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. This particular delivery order for Calquence, a medication used in oncology and immunology treatments, exemplifies the company's role within DLA's global pharmaceutical support network. The underlying IDC vehicle is designed to provide flexible pharmaceutical procurement across multiple therapeutic domains to support military healthcare programs worldwide, with the DLA planning future iterations that may involve multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/15/25 |